On Sept. 24, 2021, Moderna announced a supply agreement with the government of Peru for 20 million doses of Moderna’s COVID-19 vaccine to begin delivery in the first quarter of 2022. The COVID-19 Vaccine Moderna was not currently approved for use in Peru